feedburner

Enter your email address:

Delivered by FeedBurner

Strides gets USFDA nod for anti-allergic drug

The company said, it is focusing on building a private label business
in the US by leveraging its portfolio of products across softgels,
tablets, capsules and other proprietary formats.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-gets-usfda-nod-for-anti-allergic-drug/articleshow/73290842.cms



0 comments:

Post a Comment